Equity
-€6.1m
Debts exceed assets in financial year 2025.
BETA - CELL
Lifetime
20 annual accounts with figures on one time axis, 27 filings since 1999peak €880,614 (2024)
€17,043▼ 98.1%
lowest -€1.7m (2016)
-€139,294▼ €520,481
peak €720,651 (2006)
-€6.1m▼ €139,294
€6.4m▲ 0.9%
peak 7.8 FTE (2018)
0.1 FTE▼ 94.7%
Board16 names since 2016all names
3 directors and 2 others
Owners3 names in the annual accounts
90.48%
Documentsfilings and deeds
14-07-202617 days before the deadline
2025abbreviated format
Gross margin from €880,614 to €17,043Loss of €139,294Staff from 1.9 FTE to 0.1 FTE2 directors appointed, 2 resignations 08-07Cash from €43,242 to €1,974
Key points
from the 2025 annual accountsResult
-€139,294 -€139,294
From profit to loss in 2025, after a profit of €381,187 in 2024.
Turnover
≈ €120,000 estimated
The accounts state no turnover.
Debts
€6.4m 1,938% of the balance sheet
Financial debts 75%Suppliers 1%Taxes and wages 0%Other 24%
Of this, €47,977 falls due within a year.
Staff
0.1 FTE from 7.8 in 2018
Between 2018 and 2025, 99% of the full-time equivalents disappeared.
Position in the sector
-1838.2%
Lower solvency than 95% of companies in chemicals. Sector median 48.7% · 197 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,618 companies had the same profile as BETA - CELL has now. Each dot stands for 17 companies, two years later.
84.5%
were still trading
10.0%
stopped another way
4.5%
went bankrupt
Another 1.0% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,618 companies, not a prediction for BETA - CELL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Managing director,
Managing director,
Director,
Director, since 16-06-2025
- 90.48%equity €28.7m (2025) · 2025 annual accounts of
- 23.15%equity €87,116 (2024) · 2024 annual accounts of OPUS
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0465030668
2 directors appointed, 2 resignations
Resignations: OPUS and · Permanent representative: · Appointments: (class A director) and (class A director) · General meeting of 26-06-2025 · Gazette deed
New director
appointed, resigned · Permanent representative: · Board meeting of 22-10-2024 · Gazette deed
Permanent representative:
Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BETA - CELL Diepenbeek | €0.3m | €17,043 | -1838.2% | 0.1 |
| APOTHEEK HAEMELS Tervuren | €0.5m | €136,956 | 37.8% | - |
| Kemira Waterchemie NV Aartselaar | €1.6m | €237,390 | 77.6% | 0.6 |
| beLife Engis | €2.9m | -€18,180 | 41.7% | - |
| Ack-X Ravels | €0.05m | €11,110 | 83.7% | - |
| AVROXA Ghent | €1.8m | €170,832 | 48.4% | 1 |
| ADDITYS Tournai | €1.3m | €550,114 | 46.2% | 1 |
These companies have the same main activity as BETA - CELL: manufacture of chemicals and chemical products (NACE 20140). They are comparable in size and age: total assets between €46,400 and €2.9m, founded between 1990 and 2020.
Official details
Source: KBO- Status
- Active since 30-12-1998Normal situation
- Registered office
- 13 active companies are registered at this addressSource: KBO register, as of 12 November 2026.
- Activity
- Manufacture of chemicals and chemical productsNACE 20140and 1 other
- Establishment unit
- 2.091.444.0213590 Diepenbeek, since 28-06-1999
- Financial year end
- 31 December
- Peppol
- Reachable since 23-01-2026
Annual accounts 2025
- €330,384▼ 19.9%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 14-07-2026, 17 days before the end of the filing period
Insights on BETA - CELL
BETA - CELL files the abbreviated format. That format states no turnover. The gross margin fell from €120,143 in 2006 to €17,043 in 2025.
holds 90.48% of the shares. In December 2024, three directors stepped down. In June 2024, the Official Gazette published the appointment of as managing director.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BETA - CELL
- What is the company number of BETA - CELL?
- The company number of BETA - CELL is 0465.030.668. The VAT number is the same number with BE in front: BE 0465.030.668.
- Where is BETA - CELL based?
- The registered office is at Agoralaan A Bis, 3590 Diepenbeek.Company details
- What does BETA - CELL do?
- According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20140).
- What is the legal form of BETA - CELL?
- BETA - CELL is a public limited company (NV).
- When was BETA - CELL founded?
- BETA - CELL was founded on 30-12-1998.
- Is BETA - CELL still active?
- Yes, BETA - CELL is an active enterprise in the KBO register.
- How many employees does BETA - CELL have?
- BETA - CELL had an average of 0.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of BETA - CELL?
- The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €17,043 and 2,729 comparable companies of the same size. It probably lies between €48,000 and €290,000. It is a rough estimate.
- Is BETA - CELL profitable?
- In financial year 2025, BETA - CELL made a loss of €139,294.
- Where can I find the annual accounts of BETA - CELL?
- BETA - CELL filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BETA - CELL due?
- BETA - CELL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.